Biotech ETFs XBI and IBB are outperforming so far this year. It’s not too surprising if you use Stage Analysis since we know that bear markets are authors of bull […]
Biotech ETFs XBI and IBB are outperforming so far this year. It’s not too surprising if you use Stage Analysis since we know that bear markets are authors of bull […]